510 related articles for article (PubMed ID: 19004988)
1. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.
Lanaro C; Franco-Penteado CF; Albuqueque DM; Saad ST; Conran N; Costa FF
J Leukoc Biol; 2009 Feb; 85(2):235-42. PubMed ID: 19004988
[TBL] [Abstract][Full Text] [Related]
2. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.
Gambero S; Canalli AA; Traina F; Albuquerque DM; Saad ST; Costa FF; Conran N
Eur J Haematol; 2007 Feb; 78(2):144-51. PubMed ID: 17313560
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
Conran N; Fattori A; Saad ST; Costa FF
Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
[TBL] [Abstract][Full Text] [Related]
5. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Liem RI; O'Gorman MR; Brown DL
Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells.
Brun M; Bourdoulous S; Couraud PO; Elion J; Krishnamoorthy R; Lapoumeroulie C
Pharmacogenomics J; 2003; 3(4):215-26. PubMed ID: 12931135
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammatory state in sickle cell anemia patients is associated with HBB(*)S haplotype.
Bandeira IC; Rocha LB; Barbosa MC; Elias DB; Querioz JA; Freitas MV; Gonçalves RP
Cytokine; 2014 Feb; 65(2):217-21. PubMed ID: 24290434
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.
Keikhaei B; Mohseni AR; Norouzirad R; Alinejadi M; Ghanbari S; Shiravi F; Solgi G
Eur Cytokine Netw; 2013 Mar; 24(1):45-52. PubMed ID: 23608554
[TBL] [Abstract][Full Text] [Related]
9. Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia.
Silva DG; Belini Junior E; Torres Lde S; Ricci Júnior O; Lobo Cde C; Bonini-Domingos CR; de Almeida EA
Blood Cells Mol Dis; 2011 Jun; 47(1):23-8. PubMed ID: 21489839
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea induces the gene expression and synthesis of proinflammatory cytokines in vivo.
Navarra P; Grohmann U; Nocentini G; Tringali G; Puccetti P; Riccardi C; Preziosi P
J Pharmacol Exp Ther; 1997 Jan; 280(1):477-82. PubMed ID: 8996231
[TBL] [Abstract][Full Text] [Related]
11. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
12. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients.
Bao B; Prasad AS; Beck FW; Snell D; Suneja A; Sarkar FH; Doshi N; Fitzgerald JT; Swerdlow P
Transl Res; 2008 Aug; 152(2):67-80. PubMed ID: 18674741
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease.
Conran N; Saad ST; Costa FF; Ikuta T
Ann Hematol; 2007 Apr; 86(4):255-61. PubMed ID: 17205286
[TBL] [Abstract][Full Text] [Related]
14. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.
Pallis FR; Conran N; Fertrin KY; Olalla Saad ST; Costa FF; Franco-Penteado CF
Br J Haematol; 2014 Jan; 164(2):286-95. PubMed ID: 24383847
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin.
Assis A; Conran N; Canalli AA; Lorand-Metze I; Saad ST; Costa FF
Acta Haematol; 2005; 113(2):130-6. PubMed ID: 15802892
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
Charache S
Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
[TBL] [Abstract][Full Text] [Related]
17. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea.
Friedrisch JR; Prá D; Maluf SW; Bittar CM; Mergener M; Pollo T; Kayser M; da Silva MA; Henriques JA; da Rocha Silla LM
Mutat Res; 2008 Jan; 649(1-2):213-20. PubMed ID: 17988936
[TBL] [Abstract][Full Text] [Related]
18. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
[TBL] [Abstract][Full Text] [Related]
19. Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.
Finnegan EM; Turhan A; Golan DE; Barabino GA
Am J Hematol; 2007 Apr; 82(4):266-75. PubMed ID: 17094094
[TBL] [Abstract][Full Text] [Related]
20. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
